Fox Chase Cancer Center News

June 1, 2023

Fox Chase Cancer Center Researchers Show Alternate Response Criteria May Allow Early Outcome Prediction in Pancreatic Neuroendocrine Tumors

PHILADELPHIA (June 1, 2023) — Researchers at Fox Chase Cancer Center have utilized banked computed tomography (CT) to evaluate alternate response criteria for early prediction of outcomes in rare pancreatic neuroendocrine tumors (NETs).

VIEW STORY

May 31, 2023

Fox Chase Cancer Center Study Challenges Assumptions About Cystic Renal Masses

PHILADELPHIA (May 31, 2023)—Cystic renal masses are a common type of kidney lesion that are generally considered to be low-risk and unlikely to spread beyond the kidney. Now a new study from Fox Chase Cancer Center that was featured on the cover of the Journal of Urology, published by Wolters Kluwer sheds more light on these lesions.

VIEW STORY

May 30, 2023

Fox Chase Cancer Center Accredited by Smoking Treatment Accreditation & Recognition Program

PHILADELPHIA (May 30, 2023)—Fox Chase Cancer Center has been accredited by the Smoking Treatment Accreditation & Recognition (STAR) program, a tobacco treatment initiative funded through a grant from the Pennsylvania Department of Health.

VIEW STORY

May 30, 2023

Temple Health and Fox Chase Cancer Center Researchers Reveal the Importance of Three Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

PHILADELPHIA (May 30, 2023)—Patients with muscle-invasive bladder cancer who receive fewer than three cycles of chemotherapy prior to bladder removal surgery face higher risk of recurrence and worse survival outcomes. That’s according to research from Temple Health and Fox Chase Cancer Center that will be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.

VIEW STORY

May 26, 2023

Case Study Shows That Drug Sensitivity Testing Could Help Personalize Chronic Lymphocytic Leukemia Treatment Selection

PHILADELPHIA (May 26, 2023) — Management of chronic lymphocytic leukemia (CLL) is a rapidly evolving field, so choosing between the growing number of effective, available therapies can be challenging for both physicians and patients.

VIEW STORY

May 24, 2023

Temple-Led NCI-Funded Partnership Holds Fifth Annual Showcase

PHILADELPHIA (May 24, 2023)— “SPEECH amplifies fundamental purposes at Temple’s core: Inclusive, accessible excellence in research, education, workforce development, and community engagement,” said JoAnne Epps, Acting Temple University President, during last week’s exciting gathering at the Lewis Katz School of Medicine.

VIEW STORY

May 22, 2023

Fox Chase Cancer Center’s Dr. Mary Daly Receives Inaugural Impact Award From Basser Center for BRCA

PHILADELPHIA (May 22, 2023)—Fox Chase Cancer Center’s Mary Daly, MD, PhD, FACP, a professor in the Department of Clinical Genetics and the Timothy R. Talbot Jr. Chair in Cancer Research, was recently recognized as the first recipient of the BRCA Impact Award from Penn Medicine’s Basser Center for BRCA.

VIEW STORY

May 18, 2023

Fox Chase Physician Wins Best Poster Award at Breast Cancer Meeting for Research on Surgery to Remove Lymph Nodes

PHILADELPHIA (May 18, 2023)—Austin D. Williams, MD, MSEd, an assistant professor in the Department of Surgical Oncology at Fox Chase Cancer Center, received the Best Poster Award at the recent 24th Annual Meeting of the American Society of Breast Surgeons.

VIEW STORY

Primary tabs

Fox Chase Cancer Center News

Share